These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 10706125

  • 1. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC.
    Cancer Res; 2000 Feb 15; 60(4):1062-9. PubMed ID: 10706125
    [Abstract] [Full Text] [Related]

  • 2. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.
    Breast Cancer Res Treat; 2004 Nov 15; 88(2):177-86. PubMed ID: 15564800
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.
    Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C, Fogel M, Cohen IJ, Stark B, Goshen Y, Stein J, Zaizov R.
    Oncogene; 1997 Apr 03; 14(13):1541-5. PubMed ID: 9129144
    [Abstract] [Full Text] [Related]

  • 5. Inherited p53 gene mutations in breast cancer.
    Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N.
    Cancer Res; 1992 May 15; 52(10):2984-6. PubMed ID: 1581912
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel p53 germline alteration identified in a late onset breast cancer kindred.
    Sun XF, Johannsson O, Håkansson S, Sellberg G, Nordenskjöld B, Olsson H, Borg A.
    Oncogene; 1996 Jul 18; 13(2):407-11. PubMed ID: 8710380
    [Abstract] [Full Text] [Related]

  • 8. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA.
    Cancer Res; 2000 Aug 15; 60(16):4513-8. PubMed ID: 10969800
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population.
    Yamada H, Shinmura K, Okudela K, Goto M, Suzuki M, Kuriki K, Tsuneyoshi T, Sugimura H.
    Carcinogenesis; 2007 Sep 15; 28(9):2013-8. PubMed ID: 17690113
    [Abstract] [Full Text] [Related]

  • 10. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T.
    Clin Oncol (R Coll Radiol); 2007 Sep 15; 19(7):490-3. PubMed ID: 17572079
    [Abstract] [Full Text] [Related]

  • 11. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT, A A, Deo SS, Shukla NK, Das SN.
    Hum Mutat; 2003 Jan 15; 21(1):98-9. PubMed ID: 12497638
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Familial gastric cancer and Li-Fraumeni syndrome.
    Corso G, Pedrazzani C, Marrelli D, Pinto E, Roviello F.
    Eur J Cancer Care (Engl); 2010 May 15; 19(3):377-81. PubMed ID: 19674071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T, Malkin D, Friend S.
    Princess Takamatsu Symp; 1991 May 15; 22():61-70. PubMed ID: 1844252
    [Abstract] [Full Text] [Related]

  • 16. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T.
    Ann Acad Med Stetin; 2003 May 15; 49():27-43. PubMed ID: 15552838
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].
    Zhou YZ, Sun Q, Lin SQ, Wang J, Liu B, Li JX, Zhou YD, Ye J, Han H, Fang FD.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):294-8. PubMed ID: 15059511
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
    Güran S, Ozet A, Dede M, Gille JJ, Yenen MC.
    Cancer Genet Cytogenet; 2005 Jul 15; 160(2):164-8. PubMed ID: 15993273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.